Sen. Marco Rubio (R-FL) is questioning the Centers for Disease Control and Prevention over recent guidance for the prophylactic use of an antibiotic to prevent sexually transmitted infections, or STIs, raising the fear that the practice could have significant unintended consequences.
Rubio wrote to CDC Director Mandy Cohen this week asking about the agency’s preliminary recommendations for biological males who engage in same-sex intercourse to take the antibiotic doxycycline as a preventive measure against bacterial STIs. He said he is concerned that the recommendation will contribute to the problem of antimicrobial resistance, or AMR, when pathogens no longer respond to chemical medications to prevent and treat infectious diseases.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.